Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAVARIC: Verapamil and Magnesium Sulfate in Acute Ischemic Stroke
NCT02912663Phase 1Completed
- Start
- Oct 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in ischemic stroke comparing Verapamil + Magnesium Sulfate with Placebo (2 arms). Primary endpoint: Number of participants having no symptomatic intracranial hemorrhage at 48 hours. Started Oct 2017; status: completed.
02
Drugs
verapamilmagnesium sulfate
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02912663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912663.